ImmuneOncia Therapeutics, Inc. (KOSDAQ:424870)
South Korea · Delayed Price · Currency is KRW 3,415.00
+75.00 (2.25%)
At close: Oct 1, 2026
ImmuneOncia Therapeutics Market Cap
ImmuneOncia Therapeutics has a market cap or net worth of 305.28 billion as of October 1, 2026. Its market cap has decreased by -25.71% in one year.
Market Cap
305.28B
Enterprise Value
212.16B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
3,415.00
ChartMarket Cap Chart
Since May 19, 2025, ImmuneOncia Therapeutics's market cap has decreased from 547.53B to 305.28B, a decrease of -44.24%. That is a compound annual growth rate of -34.77%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 30, 2026 | 305.28B | -68.39% |
| Dec 30, 2025 | 965.63B | 76.36% |
| May 19, 2025 | 547.53B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| G2GBIO | 577.87B |
| HEM Pharma | 238.26B |
| DAE HWA Pharmaceutical | 212.96B |
| CellBion | 190.87B |
| NOVAREX | 177.70B |
| Vivozon Pharmaceutical | 167.56B |
| GC WellBeing | 166.45B |
| Cosmax Nbt | 149.43B |